This website uses cookies to provide you with the best experience. By using this site you agree to our use of cookies. Please read our cookie notice for more information.

Investors

Investor Information

ICON is a Global Contract Research Organisation (CRO). We specialise in the strategic development, management and analysis of programs that support Clinical Development; from compound selection to Phase I-IV clinical studies.

Our services can be implemented separately or as part of a comprehensive full service clinical programme that can help expedite the time it takes to bring a drug to market and monitor its performance and safety post approval.

Share Price NASDAQ

Price

Change

High

Data Provided by Refinitiv. Minimum 15 minutes delayed.


Recent News

Feb 24, 2021 ICON Reports Fourth Quarter and Full Year 2020 Results

Recent News

Feb 24, 2021

ICON Reports Fourth Quarter and Full Year 2020 Results


Upcoming Events

March 24, 2021 at 11:30 AM EDT KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum

Upcoming Events

March 24, 2021 at 11:30 AM EDT

KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum


Investing in ICON

Learn more about which Industry Analysts cover ICON and other investment information.

Investing in ICON

Learn more about which Industry Analysts cover ICON and other investment information.



Search Investor